PCOS and menopause overlap more than most people expect. Polycystic ovary syndrome does not disappear when your periods stop: the cycles may settle, while the insulin and heart risks that travel with the condition stay. That is why midlife care for PCOS looks different from midlife care for everyone else.
Does PCOS go away after menopause?
No. PCOS is a lifelong endocrine and metabolic condition, not a temporary problem with ovulation. What changes is the visible part. Once your ovaries stop releasing eggs, the two features that used to define the condition, irregular cycles and polycystic ovaries on ultrasound, stop being useful as tests.
The 2026 clinical guide from EMAS, the European Menopause and Andropause Society, says this directly. After menopause, menstrual pattern and ovarian morphology cannot be used to establish the diagnosis. Recognition has to rest on a diagnosis recorded earlier, or on a well-characterised reproductive history that fits the syndrome.
That has a practical consequence. If you were diagnosed at 25 and the note is buried in a paper file, ask for it to be put in your current record. It is what anchors the diagnosis now.
What PCOS is:
PCOS is a hormonal condition of high androgens, irregular ovulation and, often, ovaries with many small follicles. In adults it is diagnosed when two of three features are present: irregular or absent ovulation, clinical or biochemical signs of excess androgen, and polycystic ovarian morphology on ultrasound. There is no single blood test for PCOS, and a normal ultrasound does not rule it out. The diagnosis is clinical and rests on the pattern over time, which is one more reason a written history matters more than any single result.
Each of those criteria weakens with age. Perimenopause makes cycles irregular on its own. Follicle counts fall in everyone, and the polycystic appearance becomes harder to interpret. Androgen levels drift down too. This is why a woman who was never diagnosed can be missed at 45, and why a woman diagnosed at 25 can be told, wrongly, that she is "over it".
Why the name is changing: from PCOS to PMOS:
In 2026 an international consensus renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS. The EMAS guide explains the reasoning. The word "cysts" was always wrong, because those follicles are arrested, not pathological. And the old name kept the focus on the ovary and on fertility, when the syndrome is really a lifelong endocrine and metabolic disorder. For patients the rename is not cosmetic. A name that says metabolic makes it more likely that a lipid profile is ordered at your next review, and less likely that a normal ultrasound is read as a permission slip.
The value of the rename shows up in midlife. It puts metabolism, not the ovary, at the centre of follow-up, which is exactly where a woman in her fifties needs it.
PCOS and menopause: what improves and what does not:
Two things usually ease and one usually does not.
- Bleeding: cycles become irregular, but in PCOS they were irregular already. Some women notice lighter or more widely spaced periods and read that as improvement.
- Acne and unwanted hair: often soften as androgen production falls with age.
- Cardiometabolic risk: does not soften. This is the part that gets lost between the relief of lighter periods and the arrival of hot flushes.
The risks that stay after your last period:
The EMAS guide lists what women with PCOS carry a higher risk of: obesity, impaired glucose metabolism, type 2 diabetes, high blood pressure, abnormal blood lipids and cardiovascular disease. Those risks remain clinically relevant during the transition and afterwards, and EMAS says they should be considered in long-term follow-up. Insulin resistance, the metabolic core of the syndrome, does not switch off when oestrogen falls. The years after the last period are when a raised glucose most often starts to show, which is why this follow-up matters more, not less.
One limit on the evidence matters. EMAS states plainly that studies looking specifically at postmenopausal women with PCOS are limited. The estimates are therefore extrapolated, and the guidance is cautious rather than precise. Do not expect your clinician to quote a percentage at you.
What a midlife review should include:
EMAS recommends that care focus on cardiometabolic risk assessment. In practice that means a handful of measurements, none of them exotic:
- body weight and waist circumference
- blood pressure
- glycaemic status, measured with HbA1c or an oral glucose tolerance test
- a lipid profile
- the other standard cardiovascular risk factors, including smoking and family history
Waist circumference is worth naming. Central fat is the pattern PCOS tends toward, and fat distribution shifts with menopause, so a scale that has not moved can hide a change in where the weight sits. Two numbers you can track at home are enough: your waist and your blood pressure. Both respond to the same changes you would make anyway, and both give feedback faster than weight does.
| Area | What PCOS does | What routine care covers |
|---|---|---|
| Glucose | Insulin resistance and higher type 2 diabetes risk | HbA1c or glucose tolerance test at review |
| Blood pressure and lipids | More hypertension and dyslipidaemia | Measured and treated to standard targets |
| Weight and waist | Central fat accumulation | Diet, activity and strength work |
| Cancer screening | No extra screening from PCOS alone | The national programme, on its usual schedule |
Is HRT safe if you have PCOS?
Yes, in the same sense as for any other woman. PMOS on its own is not a contraindication to menopausal hormone therapy, and the EMAS guide says the decision to start, the regimen and the route should follow standard menopause guidance, based on your symptoms and your overall risk.
The honest caveat is the one that runs through the whole guide. Trials of hormone therapy specifically in women with PCOS are scarce. What you get is the general menopause evidence, applied to your situation. That is a reasonable basis for a decision. It is simply not a PCOS-specific trial.
There is also a practical mismatch to expect. If you took the combined pill for years to control PCOS, you may assume HRT will feel similar. It does not. Menopausal hormone therapy is not contraception, and a standard regimen does not suppress ovulation the way the pill does. If your PCOS came with high blood pressure or a high BMI, say so at the appointment, because both shape which preparation is sensible.
When a symptom is not PCOS:
New, severe or rapidly worsening excess hair growth after menopause should not be blamed on PCOS. The EMAS guide says it needs evaluation for other causes before the syndrome is accepted as the explanation. The same caution applies to any bleeding after your periods have stopped: postmenopausal bleeding is always investigated, whatever your history says.
Hot flushes, night sweats, broken sleep, brain fog and low mood are menopause symptoms. They are not PCOS symptoms. They deserve menopause treatment on their own terms, not a shrug because "you always had hormones".
Bone, muscle and weight in midlife:
EMAS does not support a separate osteoporosis screening strategy simply because you have PCOS, so you follow the same bone guidance as everyone else. What changes is the weight of the basics. Muscle falls faster after menopause, and resistance training with adequate protein is the intervention with the best evidence behind it. In PCOS that advice does double duty, because muscle is where glucose is disposed of. The workable starting point is protein at every meal and two resistance sessions a week. It is also the advice most easily postponed, and the postponement is the thing that costs you.
Contraception before your last period:
Ovulation can still happen in perimenopause, even when cycles are irregular and widely spaced, so contraception still matters until your periods have genuinely stopped. PCOS makes that judgement harder, because cycles can be erratic enough that a missed period tells you nothing.
It also creates a quiet trap. If you took the combined pill partly to control PCOS, you may think of it as a treatment. It is contraception as well, and hormone replacement is not. Stopping the pill without a plan is how unplanned pregnancies happen in the late forties. If you take a progestogen as part of hormone therapy to protect the womb lining, that is not contraception either.
Ask your clinician when you can safely stop, and what method fits your blood pressure, smoking status and migraine history.
When to see a doctor:
- Any vaginal bleeding after 12 months without a period.
- New or rapidly worsening excess hair, a deepening voice or new acne after menopause.
- Blood pressure at or above 140/90 on repeated readings.
- Unusual thirst, passing urine often, or unexplained weight loss.
- Chest pain, breathlessness, or calf pain when you walk.
- Menopause symptoms that are disrupting sleep, work or mood.
- A history of irregular cycles and a vague "you probably had PCOS" that was never written down.